MM
Martha Morrell
Chief Medical Officer

Martha Morrell insider trades: NeuroPace (NPCE) stock sales

Chief Medical Officer, NeuroPace Last trade Dec 15, 2025 37 Form 4 filings
$399K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2023
1
Company
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Martha reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 15, 2025NPCE↓ Sell$399K
Feb 21, 2025NPCE↓ Sell$1.1M
Jan 30, 2025NPCE↓ Sell$5K
Jan 24, 2025NPCE↓ Sell$48K
Feb 5, 2024NPCE↓ Sell$265K
Feb 1, 2024NPCE↓ Sell$209K
Jan 25, 2024NPCE↓ Sell$12K
Dec 27, 2023NPCE↓ Sell$136K
Dec 20, 2023NPCE↓ Sell$28K
Dec 6, 2023NPCE↓ Sell$90K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Martha Morrell's insider trades

Martha Morrell is Chief Medical Officer at NeuroPace (NPCE). Since Dec 6, 2023, Martha has reported no open-market purchases and 10 sales worth $2.3M on SEC Form 4. In the last 12 months: 1 sale ($399K).

Their filings also include shares withheld for taxes (20 filings), grants and awards (6 filings), option exercises (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NPCE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.